✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Neurocrine Biosciences Inc

Common Name
Neurocrine Biosciences
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
NBIX
Exchange
NASDAQ/NGS
Description
Neurocrine Biosciences Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for neurological and endocrine-related disorders. ...

Neurocrine Biosciences's Financial Statements Preview

Below are the financial statements of Neurocrine Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenues
Net product sales
2,330.6a
1,860.6a
1,440.9a
Collaboration revenue
24.7a
26.5a
47.8a
Total revenues
2,355.3a
1,887.1a
1,488.7a
Operating expenses
Cost of revenues
-34a
-39.7a
-23.2a
Research and development
-731.1a
-565a
-463.8a
Acquired in-process research and development
-12.5a
-143.9a
0a
Selling, general, and administrative
-1,007.2a
-887.6a
-752.7a
Total operating expenses
-1,784.8a
-1,636.2a
-1,239.7a
Operating income
570.5a
250.9a
249a
Other (expense) income
Unrealized (loss) gain on equity investments
-37.1a
28.4a
30.8a
Charges associated with convertible senior notes
-138.4a
0a
-70a
Interest income and other, net
91a
52.8a
4.1a
Total other (expense) income, net
-84.5a
81.2a
-35.1a
Income before provision for income taxes
486a
332.1a
213.9a
Provision for income taxes
-144.7a
-82.4a
-59.4a
Net income
341.3a
249.7a
154.5a
Limited Data Preview
You are viewing a limited preview of Neurocrine Biosciences’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Neurocrine Biosciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Neurocrine Biosciences’s data sources below and access millions more through our Disclosure Search.

a. Neurocrine Biosciences's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?